Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Liabilities (2022 - 2026)

Cannabis Bioscience International Holdings' Total Liabilities history spans 5 years, with the latest figure at $1.5 million for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 18.4% to $1.5 million in Q1 2026 year-over-year; TTM through Feb 2026 was $1.5 million, a 18.4% increase, with the full-year FY2025 number at $1.2 million, up 5.22% from a year prior.
  • Total Liabilities hit $1.5 million in Q1 2026 for Cannabis Bioscience International Holdings, up from $1.4 million in the prior quarter.
  • Over the last five years, Total Liabilities for CBIH hit a ceiling of $1.5 million in Q1 2026 and a floor of $405301.0 in Q4 2022.
  • Historically, Total Liabilities has averaged $1.0 million across 5 years, with a median of $1.1 million in 2024.
  • Biggest five-year swings in Total Liabilities: skyrocketed 132.85% in 2023 and later grew 5.22% in 2025.
  • Tracing CBIH's Total Liabilities over 5 years: stood at $405301.0 in 2022, then skyrocketed by 132.85% to $943726.0 in 2023, then increased by 27.11% to $1.2 million in 2024, then grew by 15.48% to $1.4 million in 2025, then grew by 6.02% to $1.5 million in 2026.
  • Business Quant data shows Total Liabilities for CBIH at $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $1.3 million in Q3 2025.